The final chapter in Matthew Perry’s tragic overdose has drawn a sharp focus on the shadowy networks that supply narcotics to the entertainment industry. On Thursday, the actor’s personal assistant, Kenneth Iwamasa, was sentenced to 27 months in prison for his role in procuring the ketamine that killed Perry last year. But the sentencing, delivered in a Los Angeles federal courtroom, laid bare a far wider story: the unsavoury trade that caters to the wealthy and vulnerable behind the velvet rope.
Iwamasa, 49, admitted to injecting the 54-year-old *Friends* star with multiple doses of ketamine on the day of his death, a pattern that had gone on for weeks. The assistant’s lawyer argued his client had been a “grieving and broken” man caught between loyalty to a demanding employer and the illegal drug market. The prosecution, however, was unmoved. “He chose to be the facilitator of an addiction,” said prosecutor Ian Morgan. “He chose to be the man who handed over the syringe.”
The case has ripped open a grim, glossy world of doctors, dealers and enablers who serve Hollywood’s darkest needs. Court documents revealed that Iwamasa had sourced ketamine from a network of three other individuals, including a doctor who prescribed the anaesthetic under false pretences and a former university colleague who acted as a middleman. One message read to the court showed Iwamasa texting a dealer: “He needs it. He can’t function without it.”
For the millions who grew up watching Perry as Chandler Bing, the details are a sickening addendum to a well-documented battle with addiction. The actor had spoken openly about his struggles with alcohol and opiates, but ketamine – a dissociative anaesthetic used in depression therapy – had become his final crutch. The question now is not just who supplied the drug, but how a system meant to help became a pipeline to disaster.
Ketamine clinics have mushroomed across the United States, offering treatment for depression and anxiety. But regulation is patchy. In Perry’s case, a doctor was charged with writing fraudulent prescriptions, while a dealer known as the “Ketamine Queen” is awaiting trial for supplying the lethal batch. The court heard how cash payments, encrypted apps and off-the-books deliveries enabled a trade that thrives on desperation.
Iwamasa’s sentence includes two years of supervised release. He wept as the judge declared that his actions “enabled a tragedy”. But for addiction charities and medical ethicists, the finger points higher. “This is not just about one assistant or one doctor,” said Dr. Rachel Steinberg, a Los Angeles-based psychologist who works with recovering addicts. “It’s about a culture that treats celebrity suffering as a commodity. The people who get paid to look the other way must also be held accountable.”
The case is a sobering reminder that addiction does not discriminate. Perry had wealth, access and a team of people whose job it was to keep him alive. Yet he died alone in a hot tub, injected by a man who was paid to run errands. As one juror told reporters afterwards: “Money buys you a lot of things. It doesn’t buy you the right to die.”
Hollywood will no doubt pay lip service to change. But until the gilded networks that supply its most vulnerable are dismantled, the next tragedy is just a phone call away.
